Protagenic Therapeutics, Inc.\new - PTIX
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FNY Investment Advisers, LLC | History | No change | 25,000 | 20 | 0.0% | 0.0% | 1 | 0 | 0.0% | Q3 2026 | Oct 16, 2026 |
| DRW Securities, LLC | History | No change | 41,783 | 16 | 0.0% | 0.0% | 2 | 0 | 0.0% | Q2 2026 | Aug 14, 2026 |